Med Services Europe GmbH, a “Virtual European Headquarters” for Pharmaceutical and Medical Manufacturers, announced that it has obtained rights to out-license a portfolio of prescription pharmaceuticals and is beginning its search for partners in Russia and the rest of Eastern and Central Europe.
Dr. Gene Emmer, President of Med Services Europe explained: “We have signed an agreement with a European-based pharmaceutical company that grants us the right to develop a network of distributors for an exciting portfolio of prescription pharmaceutical products. Our client will launch the portfolio in their home market. Med Services Europe will build and manage a network of pharmaceutical companies which will be responsible for marketing, sales and distribution of these products in their home markets. While we will be building our network world-wide, for strategic reasons, the focus of our initial efforts will be to build our base in Russia and other CIS markets (Armenia, Azerbaijan, Belarus, Kazakhstan, Kyrgyzstan, Republic of Moldova, Tajikistan, Turkmenistan, Ukraine,Uzbekistan) as well as Central European Markets (Poland, Czech Republic, Slovakia, Hungary, Romania, Slovenia, and Bulgaria) and the Baltic States (Lithuania, Latvia and Estonia).
Dr Emmer encourages pharmaceutical companies to learn more about the opportunity to in-license this portfolio of products. “This is a unique opportunity to obtain marketing rights to an exciting portfolio of products, which are effective for a large and growing market.”
Pharmaceutical companies interested in obtaining more information, particularly those located in Russia, CIS, Central European and Baltic countries are encouraged to contact Dr Emmer at Med Services Europe in Switzerland.
About Med Services Europe
Med Services Europe GmbH is located in Zurich Switzerland and specializes in Sales, Marketing and Business Development for Pharmaceutical and Medical manufacturers. Med Services acts as a virtual European Headquarters by developing and managing distribution networks for its clients.